加味参芪地黄汤联合前列地尔治疗慢性肾衰竭患者的疗效

doi:10.3969/j.issn.1671-7171.2022.05.032

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (1128 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要【目的】探讨加味参芪地黄汤联合前列地尔治疗对慢性肾衰竭患者的肾功能、炎症指标及晚期蛋白质氧化产物(AOPP)水平的影响。【方法】在本院接受治疗的100例慢性肾衰竭患者随机分为中药组(n=50)和西药组(n=50),其中西药组给予前列地尔治疗,中药组给予加味参芪地黄汤联合前列地尔治疗。比较两组患者肾功能[血肌酐(SCr)、尿素氮(BUN)、24h尿蛋白],AOPP水平,炎症指标[C反应蛋白(CRP)、白细胞介素-17(IL-17)、白细胞介素-6(IL-6)]的变化以及临床疗效和不良反应发生情况。【结果】与治疗前比较,两组患者治疗后血清SCr、BUN、24h尿蛋白、AOPP、CRP、IL-17、IL-6水平均明显降低(P<0.05),且中药组较西药组降低更为明显(P<0.05);中药组总有效率为86.00%(43/50),明显高于西药组的62.00%(31/50)(P<0.05);两组患者不良反应发生率比较,差异无统计学意义(P>0.05)。【结论】加味参芪地黄汤联合前列地尔治疗慢性肾衰竭,可有效调节患者炎症指标,降低AOPP水平,改善肾功能及氧化应激状态,且安全有效。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章
	马浩
	王春丽
	张慧敏
	强昂

关键词 ：肾功能衰竭,慢性/中西医结合疗法, 前列地尔/治疗应用, 治疗结果

Abstract：【Objective】 To investigate the effects of modified Shenqi Dihuang Decoction combined with alprostadil on renal function, inflammatory indexes and the level of advanced protein oxidation products (AOPP) in patients with chronic renal failure. 【Methods】 A total of 100 patients with chronic renal failure treated in our hospital were randomly divided into traditional Chinese medicine group (50 cases) and Western medicine group (50 cases). The western medicine group was treated with alprostadil, and the traditional Chinese medicine group was treated with modified Shenqi Dihuang Decoction combined with alprostadil. The changes of renal function [serum creatinine (SCR), urea nitrogen (BUN), 24h urinary protein], AOPP level, inflammatory indexes [C-reactive protein (CRP), interleukin-17 (IL-17), interleukin-6 (IL-6)] and clinical efficacy and adverse reactions were compared between the two groups. 【Results】 Compared with before treatment, serum SCR, BUN, 24h urinary protein, AOPP, CRP, IL-17 and IL-6 decreased significantly in the two groups after treatment (P<0.05), and the decrease in the traditional Chinese medicine group was more obvious than that in the western medicine group (P<0.05); The total effective rate of traditional Chinese medicine group was 86.00% (43/50), which was significantly higher than that of Western medicine group [62.00% (31/50) (P<0.05)]; There was no significant difference in the incidence of adverse reactions between the two groups (P>0.05). 【Conclusion】 The modified Shenqi Dihuang Decoction combined with alprostadil in the treatment of chronic renal failure can effectively regulate the inflammatory indexes, reduce the level of AOPP, improve renal function and oxidative stress, and is safe and effective.

Key words： Kidney Failure, Chronic/ZJ Alprostadil/TU Treatment Outcome

收稿日期: 2021-10-17

中图分类号:

R692.5

通讯作者: *E-mail:WangChunli666@163.com

引用本文:

马浩, 王春丽, 张慧敏, 强昂. 加味参芪地黄汤联合前列地尔治疗慢性肾衰竭患者的疗效[J]. 医学临床研究, 2022, 39(5): 756-758.
MA Hao, WANG Chun-li, ZHANG Hui-min, et al. Effect of Modified Shenqi Dihuang Decoction Combined with Alprostadil on Patients with Chronic Renal Failure. JOURNAL OF CLINICAL RESEARCH, 2022, 39(5): 756-758.

链接本文:

http://journal07.magtech.org.cn/yxlcyj/CN/10.3969/j.issn.1671-7171.2022.05.032 或 http://journal07.magtech.org.cn/yxlcyj/CN/Y2022/V39/I5/756